NCT02278965View on ClinicalTrials.gov

Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 22, 2015

Primary Completion Date

April 19, 2017

Study Completion Date

April 19, 2017

Conditions
Stage 0 Breast CarcinomaBreast NeoplasmsStage I Breast CarcinomaStage II Breast CarcinomaStage III Breast Carcinoma
Interventions
DRUG

Metformin

Metformin 850mg, oral, twice a day for 12 months

DRUG

Omega-3 fatty acids

Omega-3 fatty acids 2 capsules (560 mg each) oral, twice a day for 12 months

Trial Locations (1)

10032

Columbia University, New York

All Listed Sponsors
lead

Katherine D. Crew

OTHER

NCT02278965 - Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer | Biotech Hunter | Biotech Hunter